---
title: "B.Riley cuts AXT price target to $43 from $56 on China permit risk"
description: "Washington's curbs on Chinese optical transceivers lifted AXT's biggest customers and pointed straight at AXT's single point of failure: all of its indium phosphide is grown in China and shipped on a Beijing permit. The stock now trades below both the $43 and $90 targets its covering analysts published this month."
publisher: "The Inference"
section: "Chips"
published: 2026-11-18T19:14:01.312Z
modified: 2026-11-18T19:14:01.312Z
canonical: https://theinference.org/article/b-riley-cuts-axt-price-target-to-43-from-56-on-china-permit-risk
language: en
keywords: "AXT, Indium Phosphide, Analyst Ratings, Export Controls, Optical Networking"
---

# B.Riley cuts AXT price target to $43 from $56 on China permit risk

> Washington's curbs on Chinese optical transceivers lifted AXT's biggest customers and pointed straight at AXT's single point of failure: all of its indium phosphide is grown in China and shipped on a Beijing permit. The stock now trades below both the $43 and $90 targets its covering analysts published this month.

## The winners of the ban buy from the supplier it endangers

[Reuters reported on November 17](https://finance.yahoo.com/technology/articles/coherent-lumentum-shares-rise-us-133958005.html) that the Trump administration will press ahead with restrictions on new models of Chinese optical transceivers, the parts that carry data as light inside AI data centers, despite lobbying from [Amazon](https://theinference.org/markets/companies/amazon), Google, [Meta](https://theinference.org/markets/companies/meta), [Microsoft](https://theinference.org/markets/companies/microsoft), [Cisco](https://theinference.org/markets/companies/cisco) and [CoreWeave](https://theinference.org/markets/companies/coreweave), whose executives warned that replacing Chinese supply could take a decade [1][2].

[Coherent](https://theinference.org/markets/companies/coherent), the optical components maker, rose about 10 percent on the report and [Lumentum](https://theinference.org/markets/companies/lumentum) 8 percent before both faded, and Lumentum had already agreed, on November 2, to an all-stock takeover by [Marvell](https://theinference.org/markets/companies/marvell) worth $82.1 billion as of November 15 [1][3][4].

AXT went the other way. It closed November 17 at $36.42, down 5.3 percent [6], six days after a 23 percent one-day surge to $48.19 [5]. The same headline that lifted Coherent runs through a wafer grown outside Beijing.

## One wafer, one country, one permit desk

[AXT](https://theinference.org/markets/companies/axt-inc) grows every indium phosphide wafer it sells in China, through its subsidiary Beijing Tongmei, and since February 4, 2025, each shipment abroad has needed a case-by-case license from China's Ministry of Commerce [8][9].

![A stack of compound semiconductor wafers in a white shipping carrier](https://storage.googleapis.com/theinference-public/img/612c80cf1626a7b3.jpg)

*Compound semiconductor wafers in a shipping carrier. AXT's indium phosphide leaves China only as fast as Beijing signs export permits, and B.Riley warns customers may qualify suppliers in Germany and Japan instead. (Courtesy of AXT Inc)*

That pipeline has jammed before. AXT cut its fourth-quarter 2025 outlook on January 8, 2026, because Beijing issued fewer permits than expected, and [in an August filing](https://www.theepochtimes.com/china/china-export-curbs-delay-axts-us-bound-indium-phosphide-shipments-6084439) it called export permits its "most significant challenge", unable to say when shipments to US customers would resume [9].

## Two customers have prepaid, and B.Riley says they may leave

[B.Riley cut its target to $43 from $56 on November 17](https://finance.yahoo.com/markets/stocks/articles/axt-faces-supplier-switch-risk-174559376.html), kept a Neutral rating, and named the switch: a slower license pipeline would push customers such as Lumentum and Coherent to qualify non-Chinese suppliers, Germany's Freiberger among them [8]. Both customers already have cash committed, with Lumentum's $43.5 million July deposit on a six-year capacity reservation, which The Inference examined on November 15, and Coherent's $22.29 million prepayment on a three-year supply agreement [9](https://theinference.org/article/lumentum-s-43-5-million-deposit-leads-92-million-of-axt-prepayments-that-may-be-refunded).

## The backlog is real, and it sits behind the licenses

The quarter underneath the argument was a record: $73.4 million of revenue, up 162 percent year over year, a 56.0 percent gross margin, and [a backlog above $500 million, five times the $100 million of April](https://theinference.org/article/axt-s-indium-phosphide-backlog-tops-500-million-five-times-april-s-level-as-revenue-jumps-162), with fourth-quarter guidance near $90 million [6][7][8].

*Chart: **Revenue fell 36% in the permit squeeze, then nearly tripled to $73.4 million** Column chart of AXT quarterly revenue from the fourth quarter of 2023 to the third quarter of 2026, showing a dip through mid-2025, a steep climb to $73.41 million in the September 2026 quarter, and fourth-quarter guidance near $90 million*

*Quarterly revenue in US dollars, millions, as reported in AXT's SEC filings, with fourth-quarter 2026 guidance shown as a projection. Q3 2026 revenue of $73.41 million was a record; the guidance of about $90 million depends on how fast Beijing issues export permits. [10]*

[Nomura started coverage on November 3 at Buy with a $90 target](https://exencialrp.substack.com/p/nomura-starts-axt-at-buy-usd90-sees), resting on a 7 percent laser-chip supply shortfall it models for 2028; the same note concedes that if China eases permits, shortage turns to oversupply [7].

[GuruFocus](https://www.gurufocus.com/news/9192906/axt-inc-axti-surges-23-amid-tech-sector-rally-on-november-11-2026) puts the shares at 106.4 times trailing earnings against a five-year median of 18.7, with insiders selling $76.2 million of stock and buying none [5]. The rivals standing outside the permit queue are Sumitomo Electric and JX Advanced Metals in Japan, and Freiberger in Germany, with JX planning to lift indium phosphide capacity seven to ten times [9].

*Chart: **AXT closed at $36.42, below both the $43 and $90 targets** Bar chart of four per-share values for AXT: Nomura's $90 target and B.Riley's $43 target, both estimates, against the November 17, 2026, close of $36.42 and GuruFocus's $3.16 modeled fair value*

*Per-share values in US dollars, with analyst targets and modeled fair value shown as estimates. Targets and fair value as published between November 3 and 17, 2026, against the November 17, 2026, close. [5][6][7][8]*

## The license queue sets the price

Beijing has announced nothing. The retaliation leg is a warning industry gave reporters, not a policy, and the FCC's final text, whenever it lands, will set the timeline Washington controls [1][2]. The desk that decides this stock sits in Beijing either way: the $500 million backlog converts to revenue only as fast as China signs the permits [1][2].

## Takeaway

AXT's record quarter and $500 million backlog convert to cash only as fast as Beijing signs export permits, and with the stock at $36.42 below both this month's price targets, B.Riley warns that the wait itself may push Lumentum and Coherent to suppliers in Germany and Japan.

## Sources

1. [Yahoo Finance / GuruFocus, "Coherent and Lumentum Shares Rise as US Advances Restrictions on Chinese Data Centre Equipment", 17 November 2026](https://finance.yahoo.com/technology/articles/coherent-lumentum-shares-rise-us-133958005.html)
2. [Investing.com via Yahoo Finance, "Coherent, Lumentum jump as US presses ahead with China equipment curbs", 17 November 2026](https://finance.yahoo.com/markets/stocks/articles/coherent-lumentum-jump-us-presses-130132183.html)
3. [Yahoo Finance, "Lumentum, Corning, and other optical-related stocks jump on Chinese import restrictions", 17 November 2026](https://finance.yahoo.com/markets/stocks/article/optical-related-stocks-surge-on-import-restrictions-of-chinese-data-center-equipment-150444937.html)
4. [Simply Wall St via Yahoo Finance, "Lumentum Holdings (LITE) Heads Into An $82.1 Billion All Stock Takeover", 15 November 2026](https://finance.yahoo.com/markets/stocks/articles/lumentum-holdings-lite-heads-82-090812192.html)
5. [GuruFocus, "AXT Inc (AXTI) Surges 23% Amid Tech Sector Rally on November 11, 2026", 11 November 2026](https://www.gurufocus.com/news/9192906/axt-inc-axti-surges-23-amid-tech-sector-rally-on-november-11-2026)
6. [Business Wire via MarketScreener, "AXT, Inc. Announces Third Quarter 2026 Financial Results", 29 October 2026](https://www.marketscreener.com/news/axt-inc-announces-third-quarter-2026-financial-results-ce785fdadd80f126)
7. [Exencial Research Partners, "Nomura Starts AXT at Buy, USD90, Sees InP Shortage Into 2028", 12 November 2026](https://exencialrp.substack.com/p/nomura-starts-axt-at-buy-usd90-sees)
8. [GuruFocus via Yahoo Finance, "AXT Faces Supplier Switch Risk if US-China Tensions Flare", 17 November 2026](https://finance.yahoo.com/markets/stocks/articles/axt-faces-supplier-switch-risk-174559376.html)
9. [The Epoch Times, "China Export Curbs Delay AXT's US-Bound Indium Phosphide Shipments", 8 September 2026](https://www.theepochtimes.com/china/china-export-curbs-delay-axts-us-bound-indium-phosphide-shipments-6084439)
10. [AXT Inc, quarterly figures from its SEC filings, retrieved 18 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001051627)


---

B.Riley cuts AXT price target to $43 from $56 on China permit risk — The Inference. Canonical: https://theinference.org/article/b-riley-cuts-axt-price-target-to-43-from-56-on-china-permit-risk
